Literature DB >> 27180986

BAFF upregulates CD28/B7 and CD40/CD154 expression and promotes mouse T and B cell interaction in vitro via BAFF receptor.

Feng Zhang1, Shan-Shan Song1, Jin-Ling Shu1, Ying Li1, Yu-Jing Wu1, Qing-Tong Wang1, Jing-Yu Chen1, Yan Chang1, Hua-Xun Wu1, Ling-Ling Zhang1, Wei Wei1.   

Abstract

AIM: B cell-activating factor belonging to the TNF family (BAFF) is a member of TNF family and required for peripheral B cell survival and homeostasis. BAFF has been shown to promote the proliferation of T and B cells. In this study we examined whether and how BAFF mediated the interaction between mouse T and B cells in vitro.
METHODS: BAFF-stimulated B or T cells were co-cultured with T or B cells. The interactions between T and B cells were analyzed by measuring the expression of co-stimulatory molecules (CD28/CD80 or CD40/CD154), the proliferation and secretion of T and B cells and other factors. Two siRNAs against the transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) and BAFF receptor (BAFF-R) were used to identify the receptors responsible for the actions of BAFF.
RESULTS: BAFF-stimulated B cells significantly promoted the proliferation and activity of co-cultured T cells, and increased the percentages of CD4(+)CD28(+) and CD4(+)CD154(+) T cells. Similarly, BAFF-stimulated T cells significantly promoted the proliferation and activity of co-cultured B cells, and increased CD19(+)CD80(+) and CD19(+)CD40(+)B cell subpopulations. BAFF-R siRNA-silenced B cells showed significantly lower expression of CD40 and CD80 than the control B cells. When the BAFF-R siRNA-silenced B cells were stimulated with BAFF, then co-cultured with T cells, the expression of CD28 and CD154 on T cells was not increased. TACI siRNA-silenced B cells exhibited higher expression of CD40 and CD80 than the control B cells. When the TACI siRNA-silenced B cells were stimulated with BAFF, then co-cultured with T cells, the expression of CD28 and CD154 on T cells was significantly increased.
CONCLUSION: BAFF upregulates CD28/B7 and CD40/CD154 expression, and promotes the interactions between T and B cells in a BAFF-R-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27180986      PMCID: PMC4973375          DOI: 10.1038/aps.2016.15

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  31 in total

1.  Critical role of TNF receptor type-2 (p75) as a costimulator for IL-2 induction and T cell survival: a functional link to CD28.

Authors:  Edward Y Kim; Hung-Sia Teh
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

Review 2.  Dynamic regulation of T cell activation and co-stimulation through TCR-microclusters.

Authors:  Takashi Saito; Tadashi Yokosuka; Akiko Hashimoto-Tane
Journal:  FEBS Lett       Date:  2010-11-24       Impact factor: 4.124

3.  Effect of rhTACI-Ig fusion protein on antigen-specific T cell responses from keyhole limpet haemocyanin challenged mice.

Authors:  Qing-Tong Wang; Yu-Kun Ma; Bei Huang; Dan-Dan Liu; Wei Wei
Journal:  Mol Immunol       Date:  2011-10-02       Impact factor: 4.407

4.  BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors.

Authors:  Xin Zhang; Chan-Sik Park; Sun-Ok Yoon; Li Li; Yen-Ming Hsu; Christine Ambrose; Yong Sung Choi
Journal:  Int Immunol       Date:  2005-05-20       Impact factor: 4.823

Review 5.  CD40 ligand: a neo-inflammatory molecule in vascular diseases.

Authors:  Ghada S Hassan; Yahye Merhi; Walid Mourad
Journal:  Immunobiology       Date:  2011-04-07       Impact factor: 3.144

6.  CD28-B7 interaction modulates short- and long-lived plasma cell function.

Authors:  Modesta N Njau; Jin Hyang Kim; Craig P Chappell; Rajesh Ravindran; Leela Thomas; Bali Pulendran; Joshy Jacob
Journal:  J Immunol       Date:  2012-08-20       Impact factor: 5.422

7.  Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.

Authors:  Vassilia-Ismini Alexaki; George Notas; Vassiliki Pelekanou; Marilena Kampa; Maria Valkanou; Panayiotis Theodoropoulos; Efstathios N Stathopoulos; Andreas Tsapis; Elias Castanas
Journal:  J Immunol       Date:  2009-10-14       Impact factor: 5.422

Review 8.  CD40/CD40 ligand interactions in immune responses and pulmonary immunity.

Authors:  Tsutomu Kawabe; Miyoko Matsushima; Naozumi Hashimoto; Kazuyoshi Imaizumi; Yoshinori Hasegawa
Journal:  Nagoya J Med Sci       Date:  2011-08       Impact factor: 1.131

9.  The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway.

Authors:  Edina Schweighoffer; Lesley Vanes; Josquin Nys; Doreen Cantrell; Scott McCleary; Nicholas Smithers; Victor L J Tybulewicz
Journal:  Immunity       Date:  2013-02-28       Impact factor: 31.745

Review 10.  B-cell activating factor targeted therapy and lupus.

Authors:  Alexis Boneparth; Anne Davidson
Journal:  Arthritis Res Ther       Date:  2012-11-02       Impact factor: 5.156

View more
  6 in total

1.  BAFF, involved in B cell activation through the NF-κB pathway, is related to disease activity and bone destruction in rheumatoid arthritis.

Authors:  Ling-Ling Zhang; Hui Xiao; Feng Zhang; Yu-Jing Wu; Jin-Ling Shu; Ying Li; Yu Tai; Sheng-Qian Xu; Jian-Hua Xu; Wei Wei
Journal:  Acta Pharmacol Sin       Date:  2021-01-22       Impact factor: 7.169

2.  CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological Agents.

Authors:  Feng Zhang; Jin-Ling Shu; Ying Li; Yu-Jing Wu; Xian-Zheng Zhang; Le Han; Xiao-Yu Tang; Chen Wang; Qing-Tong Wang; Jing-Yu Chen; Yan Chang; Hua-Xun Wu; Ling-Ling Zhang; Wei Wei
Journal:  Front Pharmacol       Date:  2017-12-22       Impact factor: 5.810

3.  B-Cell Activating Factor Predicts Acute Rejection Risk in Kidney Transplant Recipients: A 6-Month Follow-Up Study.

Authors:  Xu-Zhen Wang; Zhen Wan; Wu-Jun Xue; Jin Zheng; Yang Li; Chen Guang Ding
Journal:  Front Immunol       Date:  2019-05-15       Impact factor: 7.561

Review 4.  Positive Selection in the Light Zone of Germinal Centers.

Authors:  Rinako Nakagawa; Dinis Pedro Calado
Journal:  Front Immunol       Date:  2021-03-31       Impact factor: 7.561

Review 5.  Targeting Bruton's Tyrosine Kinase in Inflammatory and Autoimmune Pathologies.

Authors:  Stefan F H Neys; Rudi W Hendriks; Odilia B J Corneth
Journal:  Front Cell Dev Biol       Date:  2021-06-04

6.  Permissive selection followed by affinity-based proliferation of GC light zone B cells dictates cell fate and ensures clonal breadth.

Authors:  Rinako Nakagawa; Amparo Toboso-Navasa; Marta Schips; George Young; Leena Bhaw-Rosun; Miriam Llorian-Sopena; Probir Chakravarty; Abdul Karim Sesay; George Kassiotis; Michael Meyer-Hermann; Dinis Pedro Calado
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-12       Impact factor: 12.779

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.